Interní Med. 2010; 12(2): 60-62

Treatment of recurrent clinical symptoms of herpetic infections

doc.MUDr.Michal Holub, Ph.D.
Klinika infekčních a tropických nemocí, 1. LF UK a FN Na Bulovce, Praha

This review article deals with recurrent herpetic infections caused by alpha herpesviruses, i.e., herpes simplex virus type 1, herpes simplex

virus type 2 and varicella zoster virus. The stress is put on the novel diagnostic methods that can be utilized routinely such as detection

of viral antigens with immunohistochemistry or the detection of deoxyribonucleid acid using polymerase-chain reaction. Also, the overview

of the current treatment methods for recurrent clinical symptoms of infections caused by alpha herpesviruses based on the use of

antiviral agents is presented. Special attention is paid to the treatment of recurrent labial and genital herpes as well as herpes zoster.

Keywords: alpha herpesviruses, recurrent infections, diagnostics, treatment, antiviral agents

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Holub M. Treatment of recurrent clinical symptoms of herpetic infections. Interní Med. 2010;12(2):60-62.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Lobovská A. Infekční nemoci. Praha: Karolinum 2002: 263 s.
    2. Lobovská A, Holub M. Diagnostika infekčních nemocí. In: Zima T, kol. Laboratorní diagnostika. 2. vydání. Praha: Galén Karolinum 2007: 639-649.
    3. Hayden FG. Antiviral drugs (other than antiretrovirals). In: Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases. Philadelphia: Elsevier Churchill Livingstone 2005: 514-550.
    4. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med 2008; 168(11): 1137-1144. Go to original source... Go to PubMed...
    5. Schmutzhard J, Merete RH, Zweygberg WB, et al. Detection of herpes simplex virus type 1, herpes simplex virus type 2 and varicella-zoster virus in skin lesions. Comparison of real-time PCR, nested PCR and virus isolation. J Clin Virol 2004; 29(2): 120-126. Go to original source... Go to PubMed...
    6. Bell DJ, Suckling R, Rothburn MM, et al. Management of suspected herpes simplex virus encephalitis in adults in a U.K. teaching hospital. Clin Med 2009; 9(3): 231-235. Go to original source... Go to PubMed...
    7. Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289(2): 203-209. Go to original source... Go to PubMed...
    8. Holub M, Aster V, Roubalová K, et al. Doporučený postup pro diagnostiku a terapii genitálního herpesu u žen. Klin mikrobiol inf lék 2009; 15(3): 102-106.
    9. van Loon AM, van der Logt JT, Heessen FW, et al. Antibody-capture enzyme-linked immunosorbent assays that use enzyme-labelled antigen for detection of virus-specific immunoglobulin M, A and G in patients with varicella or herpes zoster. Epidemiol Infect 1992; 108(1): 165-174. Go to original source... Go to PubMed...
    10. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44(Suppl 1): 1-26. Go to original source... Go to PubMed...
    11. Bojar M. Obrna lícního nervu. Čes a Slov neurol a neurochir 2007; 70(6): 613-624.
    12. Volpi A. Severe complications of herpes zoster. Herpes 2007; 14 (Suppl 2): 35-39. Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.